Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

New agency

Novartis day

Novartis doubles down on biosimilars with Biocon alliance

The companies will develop multiple immunology and oncology biosimilars

- PMLiVE

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

The bone marrow cancer therapy is now temporarily approved as a fourth-line treatment

- PMLiVE

Richard Paulson joins Ipsen as CEO for North America

He also becomes an executive vice-president at the French biopharma

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Real patient voices

The #Human behind every number project

- PMLiVE

Novartis gets speedy reviews for new Kymriah filings

US and EU regulatory agencies will review the drug for DLBCL patients

- PMLiVE

McCann Health appoints global chief digital officer

Marcus Sigurdsson is promoted from chief digital officer, Asia Pacific

- PMLiVE

Simon Doyle joins STEM

He takes up a position as vice president, global customer relations development

- PMLiVE

Merck chalks up another win for Keytruda in lung cancer

Becomes the first PD-1 inhibitor to improve OS in NSCLC patients when combined with chemo

The gold standard of scientific evidence

Will randomised controlled trials become a thing of the past?

What does programmatic advertising mean for your pharma marketing strategy?

Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.

Blue Latitude Health

Nina -Porterhouse EAP Winner 2017

Announcing the Porterhouse Entrepreneur of the Year 2017

We are delighted to announce that Nina Bull has been named the Porterhouse Entrepreneur of the Year 2017, with the overall best entry in the Porterhouse Entrepreneur Award competition last...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links